Legal Proceedings Report • Sep 11, 2014
Legal Proceedings Report
Open in ViewerOpens in native device viewer
Malakoff - FRANCE, 11 September 2014 - THERACLION (Alternext, FR0010120402 - ALTHE, PEA PME eligible), a company specialized in cutting-edge medical equipment for echotherapy, announces that the first reimbursement of the Echopulse® procedure is now available in Germany for the customers of Continentale BKK health insurance company and the health association of North of Germany and the Echotherapy Center at Marien Hospital in Bottrop.
Echopulse®, a solution developed by Theraclion will allow patients suffering from breast fibroadenoma and insured by Continentale BKK to have a free access to that non-invasive treatment at the Marien Hospital Echotherapy Center in Bottrop.
Dr. Kolberg, Gynecologic oncologist explains: "The principle of high-focused ultrasound (HIFU) is used for the non-invasive therapy of benign tumors to avoid surgery. For fibroadenoma of the breast ultrasound guided HIFU with the Echopulse®, the so called ECHOTHERAPY, is an innovative concept that combines a scar-free approach in local anesthesia with a long-term effect on the symptoms of fibroadenoma. Until now we could offer this therapy only to patients willing to pay for it. The first reimbursement contract with a general insurance is a milestone and we hope that other insurances will follow that example, thus enabling us to treat patients independently of their financial resources."
Stefan Lorenz, Chairman of the Continentale BKK, states: "We are proud to provide our customers with the advantages of the progressive treatment of Echopulse®, a gentle and effective method without invasive surgery and scars. Simultaneously this therapy reduces costs and risks which occur in case of common surgery of breast fibroadenomas."
"After obtaining the CE certification for its Echopulse in Europe from the Regulatory Bodies in December 2012, this first reimbursement with Continentale BKK is a critical milestone for Theraclion: it allows the effective kick-off of the commercialization. Now, the leading care centers which have chosen to promote our innovative non-invasive treatment can do it in a financially balanced manner. Theraclion is grateful to Continentale BKK and to the Marienhospital in Bottrop to show the path in Germany allowing thousands of patients to benefit from the non-invasive treatment of their pathology », says David Caumartin, CEO of Theraclion.
Continentale BKK is a statutory company health insurance fund. Founded in 1993, our company provides health insurance for employees in all areas of business. This includes self-employed persons, retirees as weel as students. Our goal is to maintain, restore, and improve the health of our members. As a community based on solidarity, Continentale BKK provides benefits covering the necessary medical assistance in case of illness.
Based in Malakoff, near Paris, Theraclion is a French company specialized in cutting-edge medical devices for echotherapy. Theraclion designs, develops and markets a medical device (Echopulse®) that combines advanced ultrasound imaging and HIFU therapy. Theraclion is ISO 13485 certified and has received the CE mark for noninvasive ablation of breast fibroadenomas and thyroid nodules. A full 70% of its 19-strong team are dedicated to R&D and clinical trials. For more information, visit http://www.theraclion.com.
Theraclion is listed on Alternext Paris PEA-PME Eligible Mnemonic: ALTHE - ISIN Code: FR0010120402
Theraclion NewCap. Tel.: +33 (0)1 55 48 90 70 Tel.: +33 (0)1 44 71 94 91 [email protected] [email protected]
Press Relations Caroline Carmagnol / Valentine Boivin Tel.: + 33 (0)1 70 22 53 93 [email protected]
David Caumartin Financial Communications & Investors relations CEO Emmanuel Huynh / Sophie Boulila
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.